KERVALION, a French startup founded in 2025, is pioneering the development of 3D-printed bone grafts, custom-designed from patient scans. Known for its slogan, "Surgical Bone Substitute & Regeneration", the company initially targets pre-implant dental surgery, offering bespoke grafts that resolve bone deficiencies hindering dental implant placements.
This innovative solution emphasizes personalized manufacturing, enabling grafts to precisely match patient-specific shapes and volumes. Such precision simplifies surgical procedures and reduces the number of interventions needed, offering improved biocompatibility and inspiring substantial bone regeneration. KERVALION is poised to make grafting more accessible and cost-effective for dental professionals, thereby enhancing patient comfort significantly.
The company's most recent spinout investment was made on 01 January 2025, led by University Ventures. KERVALION exemplifies a promising venture in med-tech, offering substantial value in the rapidly evolving landscape of surgical solutions.